Since corneal thickness is changed by various corneal disease, it is important to determine the normal value of the corneal thickness. Normal corneal thickness was measured by Sohn (1972) in our depatment. Also it was reported by Murata and Kato (1963), von Bahr(1948) that the corneal thickness is thinner in myopia than in emmetropia. Author measured central corneal thickness of 58 myopic eyes which divided into three groups according to the degree of myopia-group 1(-0.25D ~ 3.75D), group 2(-4.0D ~ 5.75D) and group 3(more than -6.0D)-using Haag-Streit pachometer and Mishima and Hedbys modified device to determine the changes of the corneal thickness of the myopic eyes. Results obtained as follows: 1. In group 1, group 2 and group 3, the mean value with standard deviation for the central part of the cornea was 0.497 +/- 0.012mm, 0.452 +/- 0.011mm and 0.430 +/- 0.012mm, respectively. 2. There was no significant difference of the central corneal thickness between group 1 and emmetropia. 3. However central corneal thickness of the group 2 and 3 were significantly thinner than that of group 1, respectively (P<0.001). 4. The central corneal thickness was significantly thinner in group 3 than that of group 2 (P<0.001). 5. The changes of central corneal thickness linealy decreased as the myopic degree increased from -4.0D to -7.0D.
Cornea ; Corneal Diseases ; Emmetropia ; Myopia ; Reference Values

Optic nerve gliomas are uncommon, and they and derived from altrocyte or oligodendrocyte of the optic nerve. The peak incidence is from 2 to 6 years of age. In most cases, prognosis is good and it is usually developed unilaterally. Occasionally it involves bilateral optic nerve and then usually associated with neurofibrotnatosis. Among reports of optic nerve gliomas, the incidence of neurofibromatosis varies from 12% to 38%. We have experienced of a case of bilateral optic nerve glioma not associated with neurofibromatosis in a 6 year old female patient. So the literature of the optic nerve gliomas was briefly reviewed with clinical study.
Child ; Female ; Humans ; Incidence ; Neurofibromatoses ; Oligodendroglia ; Optic Nerve Glioma* ; Optic Nerve* ; Prognosis

Choroidal neovascularization, also called subtetinal or subpigment epithelial neovasculariztation, may occur in the absence of any associated disorder and with no known etiology; in such cases, it is designated as idiopathic. Idibpathic chormdal neovascularization is characterized generally by an isolated neovascular membrane in the macula and is usually associated with a serous and/or hemorrhagic detachment of the overlying and adjacent sensory retina. The classic angiographic findings are lacy, nodular, or irregular, hyperfluorescence in the early phase, with pooling of dye in the subsensory retinal space during the late phase. The authors experienced a case of idiopathic choroidal neovascularization. A brief review of literature is described.
Choroid* ; Choroidal Neovascularization* ; Membranes ; Retina ; Retinaldehyde

The use of photocoagulation to treat proliferative diabetic retinopathy has gained widespread acceptance in ophthalmic practice since its introduction in 1959 by Meyer-Schwickerath. The purpose of photocoagulation is thought to reduce the stimulus for the vessel formation so characteristic of proliferative retinopathy. Photocoagulation may cause damage to Bruch's membrane, retinal pigment epithelium, and neurosensory retina and may result in either subretinal neovascularization or choroidal neovascularization. We found choroidal neovasaularization after performing photocogulation(one case is Argon laser the other Xenon-arch) in two diabetic retinopathy patients.
Argon ; Bruch Membrane ; Choroid* ; Choroidal Neovascularization ; Diabetic Retinopathy ; Humans ; Light Coagulation* ; Retina ; Retinal Pigment Epithelium

Inspite of technical advances, long term retinal reattachment of proliferative vitreoretinopathy following the successful surgery is often disturbed by the occurrence of cell proliferation and traction. A variety of antimetabolite or anticancer drugs have been tried to use for testing their antiproliferative effects on proliferative vitreoretinopathy. To evaluate the antiproliferative property of 5-FU, we treated with the different concentration of 5-FU(0.5, 1, 5, 10 mg/L) on cultured bovine retinal pigment epithelial cells and performed dose inhibition studies. We also examined the 5-FU treated bovine retinal pigment epithelial cells by inverted microscope daily to evaluate the morphologic change for 5 days. The results were as follows; 1. 5-FU inhibited proliferation of bovine pigment epithelial cells in a dose dependent and a time dependent manner. 2. The drug concentration required for 50% inhibition of cell growth(ID50) was found to be 1.87 mg/L. 3. As the drug concentration increased, the cell density gradually decreased and the degenerative changes such as irregular shape of cells, cytoplasmic vaculoes and cell debris were aggravated. In 10 mg/L of 5-FU treated well, disruption of cell membrane and cell death were noted from the first day of incubation. These results show that 5-FU has a potent antiprolifertive effects in retinal pigment epithelial cell and toxic effet in high dose.
Cell Count ; Cell Death ; Cell Membrane ; Cell Proliferation ; Cytoplasm ; Epithelial Cells* ; Fluorouracil* ; Retinaldehyde* ; Traction ; Vitreoretinopathy, Proliferative

The ocular manifestations of leukemic retinopathy can be divided into secondary manifestations due to hemorrhage and macular edema, and direct manifestations of leukemic infiltration. Case reports about leukemic infiltration of the optic nerve head are rare. We have experienced a case of leukemic retinopathy in a 16-year-old girl. She visited to our hospital due to sudden decrease of visual acutiy on both eyes and confirmed acute lymphocytic leukemia on bone marrow biopsy. In addition to macular edema and hemorrhage due to secondary manifestations of leukocytosis, there were sheathing noted about retinal arterioles, and disc edema were present on both eyes which seems to be the optic nerve head infiltration of leukemic cells.
Adolescent ; Arterioles ; Biopsy ; Bone Marrow ; Edema ; Female ; Hemorrhage ; Humans ; Leukemic Infiltration* ; Leukocytosis ; Macular Edema ; Optic Disk* ; Optic Nerve* ; Precursor Cell Lymphoblastic Leukemia-Lymphoma ; Retinaldehyde

Changes in the thickness and composition of Bruch's membrane with aging have been described by several observers and related to the development of macular with advancing ageby region, comparing the macular area with more peripheral areas. In the younger (less than. 50 years) eyes we studied, the thickness of macular Bruch's membrane was about equal to that of peripheral Bruch's membrane. With aging, however, the thickness of Bruch's membrane was greater in the periphery than the macula. With increasing age, Bruch's membrane increased in basophilic reaction, PAS positivity and the detectable sialomucin fraction. In the macular region, but not in more peripheral regions, there is a preferential thickening of the interchoriocapillaris "teeth" of Bruch's degeneration by some. Using a combination of histochemical and electronmicroscopic techniques, we have examined the state of Bruch's membrane membrane material. By electronmicroscopy, in older eyes, the elastin layer of Bruch's membrane appears fragmented, while, in the periphery, it is continuous and resembles that of younger eyes. In summary, Bruch's membrane exhibits little regional difference in thickness in younger eyes, but the macular region becomes relatively thinner than more peripheral regions in older eyes. With advancing age, the deposition of extracellular matrix materials in appatite and fragmentation of the elastin layer is dramatically more prominent in the macular region than in the periphery. This regional variation may be related, at least in part, to some aspects of macular degeneration.
Aging ; Basophils ; Bruch Membrane* ; Elastin ; Extracellular Matrix ; Humans* ; Macular Degeneration ; Membranes ; Periodic Acid-Schiff Reaction ; Sialomucins

A case (female, 34 years old) of pseudotumor cerebri signs with bilateral papilledema and transient diplopia secondary to the use of oral contraceptives is presented. This patient has taken habitually pills (Eugynon E.D.) for over 6 months. By fundoscopy, the moderate degree of papilledema on both eyes were observed with the slight raise of intracranial pressure. But the visual acuity was normal range at first visit day. Periodic ophthalmic examination and the education for side effects of the pills are recommended to women who are taking the pills regularly.
Contraceptives, Oral* ; Diplopia ; Education ; Female ; Humans ; Intracranial Pressure ; Papilledema* ; Pseudotumor Cerebri ; Reference Values ; Visual Acuity

Central serous chorioretinopathy is a disease which causes decreased visual acuity and functional disturbance. As the subretinal fluid is absorbed, the visual acuity is improved but patient's complaint such as metamorphosia is remained. To assess the recovery of visual functional disturbance in response to absorption of the fluid, the hue discrimination and contrast sensitivity were tested in central serous retinopathy patients (N=30) at the first visit, first visit after the absorption of subretinal fluid, and final visit. At the first visit, there were stastically significant differences in the mean square root of total error score, blue-yellow and red-green partial error score between normal control group and central serous retinopathy group and stastically significant differences in all spatial frequency between normal group and central serous retinopathy group. First visit after the absorption of subretinal fluid, and final visit, there were stastically significant differences in the mean square root of total error score, blue-yellow and red-green partial error score between normal control group and central serous retinopathy group and stastically significant differences in mid-high spatial frequency between normal group and central serous retinopathy group.
Absorption ; Central Serous Chorioretinopathy* ; Contrast Sensitivity* ; Discrimination (Psychology)* ; Humans ; Subretinal Fluid ; Visual Acuity

We report removing a large subretinal hemorrhage by means of vitrectomy combined with the use of tissue plasminogen activator(tPA) to facilitate clot removal. A 25-year-old man had a 4 days history of visual loss in the right eye after blunt trauma. The right fundus had a large subretinal hemorrhage involving macula. Surgery was performed the following day. A small retinotomy was made, through which tPA was injected into the subretinal space and through which the dissolved clot was removed. The use of tPA minimizes surgical manipulation of the retina and greatly reduces the size of the retinotomy reguired for evacuation of subretinal bood. Although the long-term prognosis is guarded, this case does suggest that tPA may be a useful adjunct in managing of subretinal hemorrhage.
Adult ; Hemorrhage* ; Humans ; Plasminogen ; Prognosis ; Retina ; Tissue Plasminogen Activator* ; Vitrectomy